Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
ConclusionCombination of CM and ADV therapy demonstrated superior HBeAg clearance compared with ADV monotherapy. The finding indicates that this combination therapy may provide an improved therapeutic effect and safety profile (ChiCTR-TRC-11001263).
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Bilirubin | China Health | Electrocardiogram | Hepatitis | Hepatitis B | Internal Medicine | Liver | PET Scan | Statistics | Study | Urology & Nephrology